Meg Mundell
-
Clinical trials explore how Low-Dose Naltrexone could help people with Long COVID
Observational studies suggest Low-Dose Naltrexone may benefit some people with Long COVID and ME. People with these diseases have shared their experiences with LDN in online communities, reflecting the value of patient knowledge. Now, LDN is attracting growing interest from researchers. Current clinical trials include a Long COVID study in Australia, a Spanish study focused…
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
What is the federal government currently doing about Long COVID?
-
U.S. scientists sequence 1,000 genomes from measles, a disease long eliminated with vaccines
-
“Not a whole lot of substance”: HHS posts Long COVID website, six months after making big promises
-
National COVID-19 trends, March 31
-
Research updates, March 31
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance